Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Ingimarsson, OddurMacCabe, James H
Haraldsson, Magnús
Jónsdóttir, Halldóra
Sigurdsson, Engilbert
Issue Date
2016-12-12
Metadata
Show full item recordCitation
Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland. 2016, 16 (1):441 BMC PsychiatryAbstract
Data on the haematological outcomes of patients who continue clozapine treatment following neutropenia are very rare as even mild neutropenia results in mandatory discontinuation of clozapine in most countries. However, in Iceland where clozapine monitoring is less stringent allows an observational study to be done on the risk of agranulocytosis and neutropenia during treatment with clozapine compared with other antipsychotics among patients with schizophrenia.The present study is a part of a wider ongoing longitudinal study of schizophrenia in Iceland. We identified 201 patients with schizophrenia treated with clozapine and 410 patients with schizophrenia who had never been on clozapine by searching the electronic health records of Landspitali, the National University Hospital. Neutrophil counts were searched in electronic databases to identify patients who developed neutropenia/agranulocytosis and the frequency of neutrophil measurements was examined as well.
The median number of days between neutrophil measurements during the first 18 weeks of clozapine treatment was 25 days but after the first 18 weeks on the drug the median became 124 days. Thirty four cases of neutropenia were identified during clozapine treatment with an average follow up time of 9.2 years. The majority, 24 individuals developed mild neutropenia (1500-1900 neutrophils/mm(3)). None of these progressed to agranulocytosis. The remaining 10 patients developed neutropenia in the range 500-1400 /mm(3) of whom one developed agranulocytosis, three stopped clozapine use and 6 patients continued on clozapine for at least a year without developing agranulocytosis. Unexpectedly, schizophrenia patients on other antipsychotics had an equal risk of developing neutropenia as those on clozapine.
Neutropenia is common both in patients with schizophrenia on clozapine treatment and in those never on clozapine. Therefore a large part of neutropenia during clozapine treatment is probably not caused by clozapine. These findings have implications in assessing the balance between the risk of progression from neutropenia to agranulocytosis against the morbidity resulting from the premature discontinuation of clozapine under the current monitoring regulations in the US and in most of Europe.
Description
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Files.Additional Links
http://dx.doi.org/10.1186/s12888-016-1167-0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153901/
Rights
openAccessae974a485f413a2113503eed53cd6c53
10.1186/s12888-016-1167-0
Scopus Count
Collections
Related articles
- Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
- Authors: Atkin K, Kendall F, Gould D, Freeman H, Liberman J, O'Sullivan D
- Issue date: 1996 Oct
- Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
- Authors: Lau KL, Yim PH
- Issue date: 2015 Dec
- Clozapine treatment and discontinuation in Iceland: A national longitudinal study using electronic patient records.
- Authors: Ingimarsson O, MacCabe JH, Haraldsson M, Jónsdóttir H, Sigurdsson E
- Issue date: 2016 Aug
- Lithium and clozapine-induced neutropenia/agranulocytosis.
- Authors: Blier P, Slater S, Measham T, Koch M, Wiviott G
- Issue date: 1998 May
- Clozapine-induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine.
- Authors: Matsui K, Ishibashi M, Kawano M, Oshibuchi H, Ishigooka J, Nishimura K, Inada K
- Issue date: 2020 Jul